Hold on to your shares: EchoStar Corp (SATS) Stock
JP Morgan raised the price target for the EchoStar Corp (NASDAQ:SATS) stock to “a Neutral”. The rating was released on January 17, 2024, according to finviz. The research report from Raymond James has downgraded the stock from Strong Buy to Outperform, with a price target set at $27. The stock was downgraded by Citigroup, who […]
Offering unique exposure at competitive prices: Amarin Corp ADR (AMRN) Stock
JP Morgan raised the price target for the Amarin Corp ADR (NASDAQ:AMRN) stock to “an Underweight”. The rating was released on November 20, 2023, according to finviz. We previously noted in another research note published on October 25, 2023 by Jefferies that downgraded the stock from a Buy to a Hold with a price target […]
ATRenew Inc ADR (RERE) Stock Experiences Incredible Growth
BofA Securities raised the price target for the ATRenew Inc ADR (NYSE:RERE) stock to “a Buy”. The rating was released on July 15, 2021, according to finviz. The latest trade, Performances and Moving Averages give us the following Picture The firm’s stock price fluctuated 10.18% within the last five trades and 55.93% within the last […]
The future of Omega Therapeutics Inc (OMGA) Stock is still in tatters?
Jefferies lowered the price target for the Omega Therapeutics Inc (NASDAQ:OMGA) stock to “a Buy”. The rating was released on May 25, 2023, according to finviz. The research report from Chardan Capital Markets has initiated the stock to Buy, with a price target set at $12. The latest trade, Performances and Moving Averages give us […]
Is this a gain, a loss, or a throwaway? Hycroft Mining Holding Corporation (HYMC) Stock
Stifel raised the price target for the Hycroft Mining Holding Corporation (NASDAQ:HYMC) stock to “a Buy”. The rating was released on October 23, 2020, according to finviz. The latest trade, Performances and Moving Averages give us the following Picture The firm’s stock price fluctuated 26.15% within the last five trades and 46.28% within the last […]
What is Omeros Corporation’s (OMER) Stock Real Technical Picture?
UBS lowered the price target for the Omeros Corporation (NASDAQ:OMER) stock from “a Buy” to “a Neutral”. The rating was released on December 08, 2022, according to finviz. We previously noted in another research note published on November 08, 2022 by BofA Securities that downgraded the stock from a Neutral to an Underperform with a […]
What are the chances of Humacyte Inc (HUMA) Stock turning the corner?
H.C. Wainwright raised the price target for the Humacyte Inc (NASDAQ:HUMA) stock to “a Buy”. The rating was released on December 11, 2023, according to finviz. We previously noted in another research note published on August 14, 2023 by Piper Sandler that upgraded the stock from an Underweight to a Neutral with a price target […]
Investing in Y-Mabs Therapeutics Inc (YMAB) Stock: Methodology
Wedbush raised the price target for the Y-Mabs Therapeutics Inc (NASDAQ:YMAB) stock from “a Neutral” to “an Outperform”. The rating was released on May 10, 2023, according to finviz. The research report from Morgan Stanley has downgraded the stock from Equal-Weight to Underweight, with a price target set at $4. In their research brief published […]
The future looks bright for C4 Therapeutics Inc (CCCC) Stock
JP Morgan raised the price target for the C4 Therapeutics Inc (NASDAQ:CCCC) stock from “an Underweight” to “a Neutral”. The rating was released on January 29, 2024, according to finviz. We previously noted in another research note published on December 13, 2023 by Stifel that upgraded the stock from a Hold to a Buy with […]
There Is Nothing Like Regenxbio Inc (RGNX) Stock
H.C. Wainwright raised the price target for the Regenxbio Inc (NASDAQ:RGNX) stock to “a Buy”. The rating was released on March 11, 2024, according to finviz. We previously noted in another research note published on March 08, 2024 by RBC Capital Mkts that upgraded the stock from a Sector perform to an Outperform with a […]
